Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-03-04 @ 9:55 PM
Study NCT ID:
NCT01319903
Status:
COMPLETED
Last Update Posted:
2012-01-13
First Post:
2011-03-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29
Sponsor:
InflaRx GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IFX-1-P1.1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None